Epidemiological features and costs of herpes zoster in Taiwan: A national study 2000 to 2006

Acta Dermato-Venereologica

Volumn 89, Issue 6, 2009, Pages 612-616

  Jih, Jaw Shyang ^a,b   Chen, Yi Ju ^a,c   Lin, Ming Wei ^a,b   Chen, Yu Chun ^a,b   Chen, Tzeng Ji ^a,b   Huang, Yu Lin ^a,b   Chen, Chih Chiang ^a,b   Lee, Ding Dar ^a,b   Chang, Yun Ting ^a,b   Wang, Wen Jen ^a,b   Liu, Han Nan ^a,b,d  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^d NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

Author keywords

Cost; Epidemiology; Herpes zoster; Post herpetic neuralgia

Indexed keywords

ANTIVIRUS AGENT; CARBAMAZEPINE; CORTICOSTEROID; GABAPENTIN; LIDOCAINE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PARACETAMOL; TRICYCLIC ANTIDEPRESSANT AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CHINESE MEDICINE; COMORBIDITY; DIABETES MELLITUS; DISEASE COURSE; FEMALE; FOLLOW UP; HEALTH CARE COST; HERPES ZOSTER; HOME CARE; HOSPITAL CARE; HOSPITAL CHARGE; HUMAN; IMMUNOCOMPROMISED PATIENT; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; NEWBORN; POSTHERPETIC NEURALGIA; PRESCHOOL CHILD; PRIORITY JOURNAL; RASH; RISK ASSESSMENT; SCHOOL CHILD; TAIWAN;

EID: 71949098660     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-0729     Document Type: Article

References (29)

1. Hope-Simpson RE. The nature of herpes zoster: a long-term study and a new hypothesis. Proc R Soc Med 1965; 58: 9-20.
2. Gnann J-WJ, Whitley R. Clinical practice. Herpes zoster. N Engl J Med 2002; 347: 340-346.
3. Bowsher D. The lifetime occurrence of herpes zoster and prevalence of postherpetic neuralgia: a retrospective survey in an elderly population. Eur J Pain 1999; 3: 335-342. (Pubitemid 30056166)
4. Brisson M, Edmunds WJ, Law B, Gay NJ, Walld R, Brownell M, et al. Epidemiology of varicella zoster virus infection in Canada and the United Kingdom. Epidemiol Infect 2001; 127: 305-314. (Pubitemid 33019542)
5. Weller TH. Varicella and herpes zoster: changing concepts of the natural history, control, and importance of a not-so-benign virus. N Engl J Med 1983; 309: 1434-1440. (Pubitemid 14245140)
6. Jung BF, Johnson RW, Griffin DR, Dworkin RH. Risk factors for postherpetic neuralgia in patients with herpes zoster. Neurology 2004; 62: 1545-1551. (Pubitemid 38608193)
7. Opstelten W, Mauritz JW, de Wit NJ, van Wijck AJ, Stalman WA, van Essen GA. Herpes zoster and postherpetic neuralgia: incidence and risk indicators using a general practice research database. Fam Pract 2002; 19: 471-475. (Pubitemid 35244231)
8. Thomas SL, Hall AJ. What does epidemiology tell us about risk factors for herpes zoster? Lancet Infect Dis 2004; 4: 26-33.
9. Chen FP, Chen TJ, Kung YY, Chen YC, Chou LF, Chen FJ, Hwang SJ. Use frequency of traditional Chinese medicine in Taiwan. BMC Health Serv Res 2007; 7: 26.
10. Health and National Health Insurance Annual Statistics Information Services. Available from: http://www.nhi.gov.tw/english/index.asp
11. Kuo HW, Tsai SS, Tiao MM, Yang CY. Epidemiological features of CKD in Taiwan. Am J Kidney Dis 2007; 49: 46-55.
12. Scott FT, Johnson RW, Leedham-Green M, Davies E, Edmunds WJ, Breuer J. The burden of herpes zoster: a prospective population based study. Vaccine 2006; 24: 1308-1314. (Pubitemid 43222038)
13. Chapman RS, Cross KR, Fleming DM. The incidence of shingles and its implication for vaccination policy. Vaccine 2003; 21: 2541-2547.
14. Czernichow S, Dupuy A, Flahault A, Chosidow O. Herpes zoster: incidence study among sentinel general pratictioners. Ann Dermatol Venereol 2001; 128: 497-501. (Pubitemid 32463580)
15. Chidiac C, Bruxelle J, Daures JP, Hoang-Xuan T, Morel P, Leplège A, et al. Characteristics of patient with herpes zoster on presentation to practitioners in France. Clin Infect Dis 2001; 33: 62-69. (Pubitemid 32554504)
16. Kang CI, Choi CM, Park TS, Lee DJ, Oh MD, Choe KW. Incidence of herpes zoster and seroprevalence of varicellazoster virus in young adults of South Korea. Int J Infect Dis 2008; 12: 245-247.
17. Heymann AD, Chodick G, Karpati T, Kamer L, Kremer E, Green MS, et al. Diabetes as a risk factor for herpes zoster infection: results of a population-based study in Israel. Infection 2008; 36: 226-230.
18. Opstelten W, Van Essen GA, Schellevis F, Verheij TJ, Moons KG. Gender as an independent risk factor for herpes zoster: a population-based prospective study. Ann Epidemiol 2006; 16: 692-695. (Pubitemid 44190173)
19. Schmader K. Herpes zoster in older adults. Aging Infect Dis 2001; 32: 1481-1486.
20. Johnson R, Whitton, TL. Management of herpes zoster (shingles) and postherpetic neuralgia. Expert Opin Pharmacother 2004; 5: 551-559. (Pubitemid 38344310)
21. Hope-Simpson RE. Postherpetic neuralgia. J R Coll Gen Pract 1975; 157: 571-675.
22. Schmader K. Epidemiology and impact on quality of life of postherpetic neuralgia and painful diabetic neuropathy. Clin J Pain 2002; 18: 350-354. (Pubitemid 35291575)
23. Strauss S, Oxman, MN, Schmader KE, editors. Fitzpatrick' s dermatology in general medicine. 7th edn. Vol.2. New York, NY: McGraw-Hill; 2008, p. 1885-1898.
24. Johnson R, Dworkin, RH. Treatment of herpes zoster and postherpetic neuralgia. BMJ 2003; 326: 748-750. (Pubitemid 36408042)
25. Di Legami V, Gianino MM, Atti MC, Massari M, Migliardi A, Tomba GS, et al. Zoster Study Group. Epidemiology and costs of herpes zoster: background data to estimate the impact of vaccination. Vaccine 2007; 25: 7598-7604.
26. Reynolds MA, Chaves SS, Harpaz R, Lopez AS, Seward JF. The impact of the varicella vaccination program on herpes zoster epidemiology in the United States: a review. J Infect Dis 2008; 197 Suppl 2: S224-S227. (Pubitemid 351590175)
27. Yih WK, Brooks DR, Lett SM, Jumaan AO, Zhang Z, Clements KM, et al. The incidence of varicella and herpes zoster in Massachusetts as measured by the Behavioral Risk Factor Surveillance System (BRFSS) during a period of increasing varicella vaccine coverage, 1998-2003. BMC Public Health 2005; 5: 68.
28. Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 2005; 352: 2271-2284.
29. Rothberg MB, Virapongse A, Smith KJ. Cost-effectiveness of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. Clin Infect Dis 2007; 44: 1280-1288. (Pubitemid 46717289)